205 related articles for article (PubMed ID: 30145351)
1. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review.
San-Juan-Rodriguez A; Newman TV; Hernandez I; Swart ECS; Klein-Fedyshin M; Shrank WH; Parekh N
Prev Med; 2018 Oct; 115():145-155. PubMed ID: 30145351
[TBL] [Abstract][Full Text] [Related]
2. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review.
Newman TV; San-Juan-Rodriguez A; Parekh N; Swart ECS; Klein-Fedyshin M; Shrank WH; Hernandez I
Res Social Adm Pharm; 2020 Sep; 16(9):1155-1165. PubMed ID: 31959565
[TBL] [Abstract][Full Text] [Related]
3. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
McConeghy KW; Wing C
Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
[TBL] [Abstract][Full Text] [Related]
4. National survey of pharmacy-based immunization services.
Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
[TBL] [Abstract][Full Text] [Related]
5. The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.
Norman WV; Soon JA; Panagiotoglou D; Albert A; Zed PJ
Contraception; 2015 Jul; 92(1):55-61. PubMed ID: 25818593
[TBL] [Abstract][Full Text] [Related]
6. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
[TBL] [Abstract][Full Text] [Related]
7. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
Anderson L; Hartung DM; Middleton L; Rodriguez MI
Obstet Gynecol; 2019 Jun; 133(6):1231-1237. PubMed ID: 31135739
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
10. Effects of educational interventions on the smoking cessation service provided by community pharmacists: A systematic review.
Appalasamy JR; Selvaraj A; Wong YH; Dujaili JA; Kow CS
Res Social Adm Pharm; 2022 Sep; 18(9):3524-3533. PubMed ID: 35168890
[TBL] [Abstract][Full Text] [Related]
11. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
Hu Y; Yao D; Ung COL; Hu H
Int J Chron Obstruct Pulmon Dis; 2020; 15():1863-1875. PubMed ID: 32821091
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
13. An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
Batra P; Rafie S; Zhang Z; Singh AV; Bird CE; Sridhar A; Sullivan JG
Obstet Gynecol; 2018 May; 131(5):850-855. PubMed ID: 29630024
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
[TBL] [Abstract][Full Text] [Related]
15. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
Patwardhan PD; Amin ME; Chewning BA
Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
[TBL] [Abstract][Full Text] [Related]
16. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of pharmacists performing obstructive sleep apnea screening services.
Cawley MJ; Warning WJ
Int J Clin Pharm; 2016 Aug; 38(4):752-60. PubMed ID: 27241341
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
19. Provision of Clinical Preventive Services by Community Pharmacists.
Kelling SE; Rondon-Begazo A; DiPietro Mager NA; Murphy BL; Bright DR
Prev Chronic Dis; 2016 Oct; 13():E149. PubMed ID: 27788064
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
Munger MA; Walsh M; Godin J; Feehan M
Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
